$CLDX Target Price Review: Celldex Therapeutics, Inc. (NASDAQ:$CLDX)
March 22, 2016 by in Stocks · 0 Comment
Street analysts that cover Celldex Therapeutics, Inc. (NASDAQ:CLDX), currently have a target price of $8.75 on company shares. 8 analysts are contributing to this target price which is the consensus number provided by Zacks Research. Each contributing analyst may have a different opinion on future stock movement. Covering analysts may look to previous resistance and support levels to assist in calculating a figure. The top target price estimate provided by analysts polled by Zacks Research is $24. The lowest target price prediction from these same analysts sits at $4. Zacks research also provides calculated recommendations from sell-side analysts that cover the stock. These recommendations fall within a simplified scale provided by Zacks Research. Using information provided from various analysts, Zacks Research lists shares of Celldex Therapeutics, Inc. with an ABR of 2. This number is based on a recommendation scale where the ratings range from a 1 to a 5. Following this scale, a 1 would indicate a Strong Buy while a 5 would indicate a Strong Sell.
We can also take a look at some company earnings per share or EPS information. Earnings per share is the segment of profit for a company that is allocated to every outstanding share of a company’s common stock. Earnings per share numbers can serve as an indicator for the profitability of a certain company. EPS is widely considered to be one of the most important factors when evaluating the price of a share. A Zacks consensus currently shows Street analysts projecting the company to post per share earnings of $-0.34. For the period ending 2015-12-31, Celldex Therapeutics, Inc. reported actual EPS of $-0.33. This number was $0.01 away from analyst predictions, providing a surprise factor of 2.94%. The company is expected to next release earnings on or around 2016-05-04.
March 22, 2016 by in Stocks · 0 Comment
Street analysts that cover Celldex Therapeutics, Inc. (NASDAQ:CLDX), currently have a target price of $8.75 on company shares. 8 analysts are contributing to this target price which is the consensus number provided by Zacks Research. Each contributing analyst may have a different opinion on future stock movement. Covering analysts may look to previous resistance and support levels to assist in calculating a figure. The top target price estimate provided by analysts polled by Zacks Research is $24. The lowest target price prediction from these same analysts sits at $4. Zacks research also provides calculated recommendations from sell-side analysts that cover the stock. These recommendations fall within a simplified scale provided by Zacks Research. Using information provided from various analysts, Zacks Research lists shares of Celldex Therapeutics, Inc. with an ABR of 2. This number is based on a recommendation scale where the ratings range from a 1 to a 5. Following this scale, a 1 would indicate a Strong Buy while a 5 would indicate a Strong Sell.
We can also take a look at some company earnings per share or EPS information. Earnings per share is the segment of profit for a company that is allocated to every outstanding share of a company’s common stock. Earnings per share numbers can serve as an indicator for the profitability of a certain company. EPS is widely considered to be one of the most important factors when evaluating the price of a share. A Zacks consensus currently shows Street analysts projecting the company to post per share earnings of $-0.34. For the period ending 2015-12-31, Celldex Therapeutics, Inc. reported actual EPS of $-0.33. This number was $0.01 away from analyst predictions, providing a surprise factor of 2.94%. The company is expected to next release earnings on or around 2016-05-04.
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
